Sign in

CIK 0001314102

  • Non-accelerated filer
  • Smaller reporting company

EyePoint, Inc.

Sign in to watch
Ticker
EYPT
Exchange
Nasdaq
Industry
Laboratory Analytical Instruments
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262774444
Phone
+1 617-926-5000
Business address
480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
Former names
EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
  1. 4 Derivatives Options or other derivatives
  2. 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 8,333 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 6,667 shares (option exercise)
  7. 4 Exercise or conversion President & CEO acquired 45,000 shares (option exercise)
  8. 4 Shares withheld for taxes Ross Leonard S gave up 2,394 shares (to pay taxes)
  9. 4 Shares withheld for taxes Chief Medical Officer gave up 4,175 shares (to pay taxes)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market buy Director bought 40,000 shares at $1.74 ($69,600)
  13. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  14. 4 Open-market buy Director bought 5,000 shares at $1.89 ($9,450)
  15. 4 Exercise or conversion Ross Leonard S acquired 5,000 shares (option exercise)
  16. 4 Open-market buy President & CEO bought 28,500 shares at $1.76 ($50,246)
  17. 4 Exercise or conversion Director acquired 20,000 shares (option exercise)
  18. 4 Open-market buy Director bought 17,000 shares at $1.75 ($29,784)
  19. 4 Shares withheld for taxes Chief Medical Officer gave up 1,188 shares (to pay taxes)
  20. 4 Shares withheld for taxes Ross Leonard S gave up 1,735 shares (to pay taxes)

Page 14 of 23 · 459 filings